HARVARD BIOSCIENCE, INC. Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, Net of Tax
HARVARD BIOSCIENCE, INC. (HBIO) reported Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, Net of Tax of $92.00 thousand for the 3-month period ending 2020-09-30, per its 10-Q filed 2020-11-06.
Discontinued › Income Statement › Unrealized Gains
us-gaap:OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax · last filed 2020-11-06
- HARVARD BIOSCIENCE, INC. other comprehensive income (loss), derivatives qualifying as hedges, net of tax for the quarter ending 2020-09-30 was $92.00K.
- HARVARD BIOSCIENCE, INC. other comprehensive income (loss), derivatives qualifying as hedges, net of tax for the quarter ending 2020-06-30 was $86.00K.
- HARVARD BIOSCIENCE, INC. other comprehensive income (loss), derivatives qualifying as hedges, net of tax for the quarter ending 2020-03-31 was -$144.00K.
- HARVARD BIOSCIENCE, INC. other comprehensive income (loss), derivatives qualifying as hedges, net of tax for the quarter ending 2019-12-31 was $66.00K.
- HARVARD BIOSCIENCE, INC. other comprehensive income (loss), derivatives qualifying as hedges, net of tax for fiscal 2019 was -$433.00K.
- HARVARD BIOSCIENCE, INC. other comprehensive income (loss), derivatives qualifying as hedges, net of tax for fiscal 2018 was -$207.00K, a 659.46% decline from fiscal 2017.
- HARVARD BIOSCIENCE, INC. other comprehensive income (loss), derivatives qualifying as hedges, net of tax for fiscal 2017 was $37.00K, a 270.00% increase from fiscal 2016.
- HARVARD BIOSCIENCE, INC. other comprehensive income (loss), derivatives qualifying as hedges, net of tax for fiscal 2016 was $10.00K, a 25.00% increase from fiscal 2015.
| Period end | Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, Net of Tax 3 month | Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, Net of Tax 6 month | Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, Net of Tax 9 month | Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, Net of Tax 12 month |
|---|---|---|---|---|
| 2020-09-30 | $92.00K 10-Q · filed 2020-11-06 | $178.00K derived: sum of 2 quarters · filed 2020-11-06 | $34.00K 10-Q · filed 2020-11-06 | $100.00K derived: sum of 4 quarters · filed 2020-11-06 |
| 2020-06-30 | $86.00K 10-Q · filed 2020-08-10 | -$58.00K 10-Q · filed 2020-08-10 | $8.00K derived: sum of 3 quarters · filed 2020-08-10 | -$33.00K derived: sum of 4 quarters · filed 2020-11-06 |
| 2020-03-31 | -$144.00K 10-Q · filed 2020-05-08 | -$78.00K derived: sum of 2 quarters · filed 2020-05-08 | -$119.00K derived: sum of 3 quarters · filed 2020-11-06 | -$398.00K derived: sum of 4 quarters · filed 2020-11-06 |
| 2019-12-31 | $66.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-16 | $25.00K derived: sum of 2 quarters · filed 2020-11-06 | -$254.00K derived: sum of 3 quarters · filed 2020-11-06 | -$433.00K 10-K · filed 2020-03-16 |
| 2019-09-30 | -$41.00K 10-Q · filed 2020-11-06 | -$320.00K derived: sum of 2 quarters · filed 2020-11-06 | -$499.00K 10-Q · filed 2020-11-06 | |
| 2019-06-30 | -$279.00K 10-Q · filed 2020-08-10 | -$458.00K 10-Q · filed 2020-08-10 | ||
| 2019-03-31 | -$179.00K 10-Q · filed 2020-05-08 | |||
| 2018-12-31 | -$207.00K 10-K · filed 2020-03-16 | |||
| 2017-12-31 | $37.00K 10-K · filed 2019-03-18 | |||
| 2016-12-31 | $10.00K 10-K · filed 2018-03-16 | |||
| 2015-12-31 | $8.00K 10-K · filed 2018-03-16 | |||
| 2014-12-31 | $31.00K 10-K · filed 2017-03-17 | |||
| 2013-12-31 | -$49.00K 10-K · filed 2016-04-29 | |||
| 2012-12-31 | $0.00 10-K · filed 2015-03-12 | |||
| 2011-12-31 | $0.00 10-K · filed 2014-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |